Akagera Medicines has reported positive data from the SAD segment of its first-in-human Phase I trial of AKG-100, an investigational...
Halozyme Therapeutics has signed a global partnership and licence agreement with Incyte to assess additional subcutaneous formulations of INCA033989 in...
Polyethylene implant company Poriferous has received a patent from the US Patent and Trademark Office (USPTO) for its DuraBloc technology.The...
Bayer and Henry Ford Health have entered a strategic research partnership aimed at expanding access to clinical trials for patients.The...
Aptar Pharma has launched a collaborative system-level framework designed to support the development of injectable drug delivery systems.The post Aptar...
GE HealthCare and Catholic Health have signed a 10-year strategic alliance valued at around $500m, aimed at expanding access to...
Grifols has dosed the first patients in two separate Phase III trials designed to support the US label expansion of...
The UK’s Joint Committee on Vaccination and Immunisation (JCVI) has recommended a routine programme with the 4CMenB vaccine for adolescents.The...
Kairos Pharma has reported interim safety results from its ongoing Phase I trial of ENV-105, along with AstraZeneca's Tagrisso, in...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.